8th Annual Rare Disease Day Genomics Symposium: Dr. Fajgenbaum’s Unique Perspective
source: pixabay.com

8th Annual Rare Disease Day Genomics Symposium: Dr. Fajgenbaum’s Unique Perspective

As part of ongoing events surrounding Rare Disease Day, which is officially recognized on the last day of the month of February, Patient Worthy attended sessions of the 8th Annual…

Continue Reading 8th Annual Rare Disease Day Genomics Symposium: Dr. Fajgenbaum’s Unique Perspective
Miss Teen USA Hopeful Becomes the First Youth Ambassador for the Aneurysm and AVM Foundation
source: pixabay.com

Miss Teen USA Hopeful Becomes the First Youth Ambassador for the Aneurysm and AVM Foundation

Arteriovenous malformation (AVM) is a rare disease that causes blood vessels to clump together within the skull. It can lead to aneurisms, strokes, or early death. However, surgery is possible…

Continue Reading Miss Teen USA Hopeful Becomes the First Youth Ambassador for the Aneurysm and AVM Foundation
The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
source: pixabay.com

The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer

Dr. Oliver Dorigo of the Stanford University Medical Center was the medical source for an article featured in Oncology. Dr. Dorigo explained that if a woman with ovarian cancer has…

Continue Reading The FDA Has Approved Niraparib (Zejula) for Platinum-Sensitive Recurrent Ovarian Cancer
Data Ownership as Leverage in Accelerating Rare Disease Drug Development
source: pixabay.com

Data Ownership as Leverage in Accelerating Rare Disease Drug Development

Patient groups can optimize patient registries, cross-sectional studies, and/or longitudinal natural history studies to maximize collaborations with sponsors of orphan drugs and gene therapies. Written by Harsha Rajasimha, MS, PhD…

Continue Reading Data Ownership as Leverage in Accelerating Rare Disease Drug Development